First, treatment with SF (5 μM for 24 h) increased frataxin protein expression, promoted axonal re-growth in frataxin-silenced motor neurons and restored Nrf2 transcriptional activity in fibroblasts from patients with FRDA (99). Here, FXN is linked to Friedreich ataxia.